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Abstract
Motivation: Function annotations of gene products, and phenotype annotations of genotypes, pro-
vide valuable information about molecular mechanisms that can be utilized by computational
methods to identify functional and phenotypic relatedness, improve our understanding of disease
and pathobiology, and lead to discovery of drug targets. Identifying functions and phenotypes
commonly requires experiments which are time-consuming and expensive to carry out; creating
the annotations additionally requires a curator to make an assertion based on reported evidence.
Support to validate the mutual consistency of functional and phenotype annotations as well as a
computational method to predict phenotypes from function annotations, would greatly improve
the utility of function annotations.
Results: We developed a novel ontology-based method to validate the mutual consistency of func-
tion and phenotype annotations. We apply our method to mouse and human annotations, and
identify several inconsistencies that can be resolved to improve overall annotation quality. We also
apply our method to the rule-based prediction of regulatory phenotypes from functions and dem-
onstrate that we can predict these phenotypes with Fmax of up to 0.647.
Availability and implementation: https://github.com/bio-ontology-research-group/phenogocon
Contact: robert.hoehndorf@kaust.edu.sa
1 Introduction
Although several definitions of what constitutes a phenotype have
been proposed over time, a phenotype can be operationally defined
as an observable characteristic of an organism arising from interac-
tions between the organism’s genotype and the environment
(Johannsen, 1909, 1911). Understanding the molecular and func-
tional basis of phenotypes is an important factor in our understand-
ing of disease mechanisms.
Abnormal phenotypes associated with loss of gene function
provide valuable information for a variety of computational methods,
such as identification of gene-disease associations (Hirschhorn et al.,
2002), protein-protein interactions (Hu et al., 2011; Kahanda et al.,
2015), disease causative variant prioritization (Boudellioua et al., 2017),
finding orthologous genes (Hoehndorf et al., 2011), and drug discovery
(Moffat et al., 2014) and repurposing (Hoehndorf et al., 2014).
Identifying which phenotypes a gene may be associated with is challeng-
ing; even in the case of a complete loss of function of a gene, phenotypes
may be highly variable (de Angelis et al., 2015).
Several consortia and research initiatives aim to systematically
catalog the phenotypes associated with loss of function mutations in
model organisms (Ring et al., 2015), and the experimental results
produced by these initiatives provide valuable information for
understanding gene function (Ring et al., 2015) or their role in
disease (Meehan et al., 2017). In addition to high-throughput phe-
notyping, there are also ongoing efforts to identify genotype–pheno-
type relations from literature (Smith and Eppig, 2015), and to
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record phenotypes observed in a clinical setting which are associated
with particular genotypes (Landrum et al., 2014).
There are several computational methods available for predict-
ing the functions of proteins (Cozzetto et al., 2016; Gong et al.,
2016; Kulmanov et al., 2017). Computational methods for function
prediction have improved in predictive performance and, subse-
quently, in their utility, over recent years (Radivojac et al., 2013).
Consequently, it is a reasonable question to ask whether the same or
similar approaches may also work for phenotypes, i.e. whether we
can build efficient methods to predict phenotypes from genotypes,
and whether these methods can provide information that may be of
clinical utility. While methods for protein function prediction are
maturing, computational methods to predict phenotypes are still in
their infancy.
There are many challenges in predicting phenotypes, both bio-
logically and computationally. From a biological perspective, pre-
dicting the phenotypes that arise from a particular genotype is
challenging due to the complex molecular and physiological interac-
tions that give rise to phenotypes, open-ended environmental influ-
ences and determinants of phenotypes, incomplete penetrance and
resilience of organisms to certain phenotypic manifestations, epigen-
etic regulation not detectable on the level of a genotype, and many
other factors contributing to the variability and heterogeneity of
phenotypes. The impact of pleiotropy and genetic background were
themselves instrumental in motivating the very large scale knockout
mouse project (IKMC), precisely because of the problems intrinsic
to predicting phenotype from genotype (Austin et al., 2004; Tyler
et al., 2016).
From a computational perspective, there are also several add-
itional challenges. First, there is a substantial lack of potential train-
ing data that limits the application of machine learning approaches.
The high variability in phenotypes and their descriptions (Gkoutos
et al., 2005) makes it challenging to identify whether genotypes are
involved in identical or similar phenotypes. There is also a lack of
computationally represented background knowledge necessary to
determine the relationship between phenotypes and their physio-
logical and patho-physiological basis; in particular, there is no com-
putationally accessible, qualitative representation of physiological
interactions in mammals. Furthermore, representation of environ-
mental influences is challenging, partly due to their heterogeneity,
but also failure to capture environmental parameters in many phe-
notyping studies (Beckers et al., 2009; Schofield et al., 2016).
The premise underlying comprehensive phenotyping studies is
that, uniquely, the phenotype of an organism lacking a functioning
copy of a given gene provides definitive information on gene func-
tion; the primary goal of functional genomics. Here, we investigate
the relationship between Gene Ontology (GO) (Ashburner et al.,
2000) functions that are associated with gene products, and pheno-
types associated with a loss of function in these gene products (either
through targeted or random mutation, epigenetic modification or
pharmaceutical effects). Our aim is to identify how much informa-
tion functions of gene products carry about the phenotypes in which
these gene products are involved. Specifically, we test the hypothesis
that a loss of a regulatory function (i.e. the up- or down-regulation
of some other process) will result in a regulatory phenotype. For ex-
ample, if a protein is (unconditionally) involved in a positive regula-
tion of B cell apoptosis, then a loss of function in that protein
should lead to a phenotype in which the rate of B cell apoptosis is
decreased. We first formalize our assumptions in meta-rules that re-
late axioms in the Web Ontology Language (OWL) (Grau et al.,
2008). We then test how many function–phenotype pairs in the la-
boratory mouse (Mus musculus) and the human (Homo sapiens)
satisfy these rules, how many annotations are consistent with our
hypothesis, and how many annotations are not consistent with out
hypothesis. We investigate some of the inconsistent pairs we iden-
tify, and characterize the reasons for the inconsistency; we find that
they can be a result of incomplete or under-specified contextualiza-
tion of function or phenotype annotations (such as by cell type),
conflicting annotation derived from literature, or a consequence of
inference over the ontology structure.
After validating and characterizing possible inconsistent annota-
tions, we apply our hypothesis predictively and predict regulatory
phenotypes associated with loss of function mutations in 11 987
gene products in the mouse and 15 680 in the human. We validate
our predictions by predicting protein-protein interactions using
phenotype similarity and demonstrate that our rules result in predic-
tions that can reproduce known associations.
2 Materials and methods
2.1 Data sources
We use functional and phenotypic annotations for mouse and
human. We downloaded Gene Ontology (GO) (Ashburner et al.,
2000) annotations from http://geneontology.org/ on December 15,
2017. The file contains 439 128 distinct annotations to 19 452
human gene products, and 376 532 distinct annotations to 24 526
mouse gene products. We use the phenotype annotations for mouse
downloaded from the Mouse Genome Informatics (MGI) (Smith
and Eppig, 2015) database (http://www.informatics.jax.org/down
loads/reports/index.html) on December 5, 2017. We use the
MGI_Gene_Pheno.rpt file which contains phenotypes for non-
conditional loss of function mutations in single genes; the file
contains phenotypes for 11 887 mouse genes and 206 272 distinct
associations between a gene and a Mammalian Phenotype Ontology
(MP) (Smith and Eppig, 2015) class. For human, we downloaded
annotations provided by the Human Phenotype Ontology (HPO)
database (Robinson et al., 2008) on December 5, 2017. We use the
file containing phenotypes from ‘all sources’ and ‘all frequencies’;
the file contains phenotype associations for 3682 human genes and
120 289 distinct associations between human genes and HPO
classes.
For reasoning and processing formal definitions of phenotypes,
we use the multi-species integrated PhenomeNET ontology
(Hoehndorf et al., 2011; Rodrı´guez-Garcı´a et al., 2017). We down-
loaded the latest version of the PhenomeNET ontology from the
AberOWL (Hoehndorf et al., 2015) ontology repository http://aber-
owl.net/ontology/PhenomeNET/. We also downloaded the GO in its
OWL format, released on December 2, 2017, from the AberOWL
ontology repository.
2.2 Filtering GO annotations
To obtain only experimental GO annotations, we filtered all GO
annotations by their evidence codes so that we only retain annota-
tions with an experimental evidence. Specifically, we only keep
annotations with evidence codes EXP, IDA, IPI, IMP, IGI, IEP,
TAS and IC. We removed all annotations which are negated (i.e.
using a NOT qualifier); we also excluded all annotations that are
context specific, i.e. which are explicitly conditional on a particular
environment or other restrictions (such as occurring only in particu-
lar cell types, or tissues, or during certain developmental stages).
After filtering all annotations, our GO annotation set contains
100 336 annotations to 11 987 mouse gene products and 295 357
annotations to 15 680 human gene products. We mapped all protein
i858 M.Kulmanov et al.
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identifiers to MGI identifiers for mouse proteins, and to HUGO
(Yates et al., 2017) standard human gene names.
2.3 Protein–protein interactions
For further validation of our predictions, we use protein-protein
interactions provided by the STRING Database (Szklarczyk et al.,
2015). STRING database uses different data sources such as high
throughput lab experiments, conserved co-expressions, text mined,
computationally predicted interactions and indirect functional asso-
ciations and provide a confidence score for each pair of proteins. We
downloaded all mouse and human protein-protein interactions from
STRING version 10.5 and filtered the interactions by a confidence
score higher or equal to 300. We use the protein.aliases file
provided by the STRING database to map STRING protein identi-
fiers to MGI identifiers (for mouse genes and proteins) and HUGO
gene names (for human genes and proteins).
2.4 Computing semantic similarity
We measure the similarity between sets of MP and HPO classes
by computing Resnik’s pairwise similarity measure using the
PhenomeNET Ontology (Hoehndorf et al., 2011), and using the
Best-Match-Average (BMA) (Pesquita et al., 2009) strategy to com-
bine pairwise similarities into a single similarity score between two
sets of annotations. We use the normalized similarity value as a pre-
diction score for interactions between proteins and compute the area
under the receiver operating characteristic (ROC) curve (Fawcett,
2006) as a quantitative measure of predictive performance.
Resnik’s similarity measure uses the information content (IC).
IC is computed as the probability of occurrence of a class in
annotations:
ICðcÞ ¼ logðpðcÞÞ
The similarity value between two classes is the IC of the most in-
formative common ancestor (MICA), i.e.:
SimResnikðc1; c2Þ ¼ ICðMICAðc1; c2ÞÞ
For two sets of classes we compute the similarity value between
each pair and use the BMA combination strategy:
SimBMAðA;BÞ
¼ avgc12Aðmaxc22Bðsðc1; c2ÞÞÞ þ avgc12Bðmaxc22Aðsðc1; c2ÞÞÞ
2
where sðx; yÞ ¼ SimResnikðx; yÞ.
2.5 Evaluation metrics
We evaluate predictions of regulatory phenotypes using Fmax meas-
ure which is used in CAFA challenge (Radivojac et al., 2013). The
Fmax measure is a type of similarity measure between predicted and
real annotations which takes ontology structure into account. It is
computed using the following formulas:
priðtÞ ¼
P
pIðp2PiðtÞ^p2TiÞP
pIðp2PiðtÞÞ
(1)
rciðtÞ ¼
P
pIðp2PiðtÞ^p2TiÞP
pIðp2TiÞ
(2)
AvgPrðtÞ ¼ 1
mðtÞ 
XmðtÞ
i¼1
priðtÞ (3)
AvgRcðtÞ ¼ 1
n

Xn
i¼1
rciðtÞ (4)
Fmax ¼ max
t
2  AvgPrðtÞ  AvgRcðtÞ
AvgPrðtÞ þAvgRcðtÞ
 
(5)
In these measures, p is a phenotype class, PiðtÞ is a set of pre-
dicted classes for a gene i using a threshold t, and Ti is a set of anno-
tated classes for a gene i. Precision is averaged over the genes where
we at least predict one term and m(t) is the total number of such
genes. n is a number of all genes in a evaluation set. We evaluate pre-
dictions for mouse genes with experimental annotations where we
at least make one prediction.
2.6 Predicting protein functions with DeepGO
In order to evaluate our method for predicting phenotypes from
functions for gene products without experimental annotations, we
predicted GO function annotations using the DeepGO function pre-
diction system (Kulmanov et al., 2017). We downloaded SwissProt
reviewed human and mouse protein sequences from the UniProt
database (The UniProt Consortium, 2017) on January 28, 2018.
Initially, our dataset had 16 950 mouse and 20 244 human pro-
teins. To meet the DeepGO requirements and limitations, we filtered
this set of proteins and removed all sequences with ambiguous
amino acid symbols (i.e. B, O, J, U, X and Z); we also removed all
proteins with >1002 amino acids. After filtering, we retained
14 916 mouse and 17 837 human proteins for which we could pre-
dict functions using DeepGO. We mapped UniProt identifiers to
MGI identifiers and HUGO gene names.
2.7 Implementation
We implemented our approach using the OWL API (Horridge and
Bechhofer, 2011) version 4.1.0 and used the Similarity Measures
Library (Harispe et al., 2014) for measuring semantic similarities.
The source code, documentation and data files are freely available at
https://github.com/bio-ontology-research-group/phenogocon.
3 Results
3.1 The correspondence between regulation and
regulatory phenotypes
Our main hypothesis is that there should be a close relationship be-
tween some functions to which gene products are annotated and
some phenotypes. In particular, if a gene product is involved in the
up- or down-regulation of a process P, then a loss-of-function of
that gene product (introduced, for example, through a pathogenic
variant, a targeted mutation, or an epigenetic interference) will usu-
ally lead to a phenotype in which the rate or intensity of P is
decreased or increased.
Specifically, we assume that, if a phenotype is defined as a
change of some biological process (such as an increased or decreased
rate or turnover of the process), then we can annotate the gene prod-
ucts which negatively or positively regulate or contribute to P bio-
logical process with the given phenotype. For example, when a
protein that is normally involved in positive regulation of B cell
apoptotic process (GO: 0002904) is inhibited (for example through
a genetic mutation, or through a small molecule which inhibits the
protein), we would expect the rate with which processes of the type
B cell apoptotic process (GO: 0001783) occur to decrease.
We formalize this hypothesis in the form of rules that assign a
new annotation to a protein with a particular function annotation.
Ontology-based phenotype prediction i859
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Let X be a protein involved in (i.e. annotated with) the function P.
We then implement our hypothesis through the following three
(meta-)rules:
• Increased Function–Decreased Phenotype: If P SubClassOf
‘positively regulates’ some P2, then a loss of function
of X results in the phenotype ‘phenotype of’ some (P2 and
‘has quality’ some ‘decreased quality’).
• Decreased Function–Increased Phenotype: If P SubClassOf
‘negatively regulates’ some P2, then a loss of function of
X results in the phenotype ‘phenotype of’ some (P2 and
‘has quality’ some ‘increased quality’).
• Abnormal Function–Abnormal Phenotype: A loss of function of
X results in the phenotype ‘phenotype of’ some [P and ‘has
quality’ some (‘has modifier’ some abnormal)].
While the first two rules directly implement our hypothesis, the
third rule establishes a correspondence between a loss of GO func-
tion and the resulting phenotype; it is, in a sense, more general than
the previous two rules which establish a correspondence between
regulatory functions and phenotypes. The inverse of the abnormality
rule has previously been used to predict GO functions from pheno-
types (Hoehndorf et al., 2013).
To determine whether a pair of classes in GO and a phenotype
ontology class match our hypothesis and subsequent rules, we use
the formal definitions and axioms that constrain the GO classes and
the classes in phenotype ontologies. Over the past years, many
classes in phenotype ontologies have been formally defined using
definition patterns based on the Entity–Quality (EQ) method
(Gkoutos et al., 2005, 2017; Mungall, 2009). In the EQ method,
phenotypes are decomposed into an entity—either an anatomical en-
tity or a biological process or function—and a quality. We identify
the GO class underlying each phenotype in MP and HPO based on
these EQ-based definition patterns, and we also identify for each
phenotype the direction (i.e. increased or decreased) in which the
process or function is modified. As a result, we obtain, for each
phenotype class in HPO or MP that is based on an abnormal func-
tion or process, a pair of a GO class and a direction (i.e. increased or
decreased) in which the rate of the process is changed. For example,
the class Increased thymocyte apoptosis (MP: 0009541) is defined
using the Entity Thymocyte apoptotic process (GO: 0070242) and
the Quality Increased rate (PATO: 0000912); the Quality is further
constrained by adding the Abnormal (PATO: 0000460) quality (in
order to distinguish the abnormal phenotype from a physiological
increase in thymocyte apoptotic rate). From the definitions we ob-
tain the pair Thymocyte apoptotic process (GO: 0070242) and
Increased as characteristic of the Increased thymocyte apoptosis
phenotype.
In total, there are 1543 classes in MP which are based on GO
processes or functions; of these, 272 classes are increased in rate,
342 classes are decreased in rate and 929 classes are abnormalities
of a process or function. In HPO, 287 phenotype classes are based
on GO processes or functions, of which 17 are increased in rate, 54
are decreased in rate and 216 are abnormalities of a process or
function.
As next step in our workflow, we identify all GO processes that
up- or down-regulate other processes. For this purpose, we use the
Elk OWL reasoner (Kazakov et al., 2012) to query GO for all
equivalent classes of ‘Biological regulation’ and ‘posi-
tively regulates’ some X and ‘Biological regulation’
and ‘negatively regulates’ some X, for all classes X. In total,
we identify 3013 processes that positively regulate another
biological process, and 3043 processes that negatively regulate an-
other biological process.
We then match the processes that are known to up- or down-
regulate other process according to GO and the processes used to de-
fine phenotype classes to find corresponding pairs. In total, we iden-
tify 1570 correspondence rules between GO and phenotype classes
of which 1328 classes are from MP and 242 classes are from HPO.
The complete set of correspondences between a GO class and
phenotype class is available on our project website. We use the cor-
respondences between regulatory phenotypes and GO functions in
two ways: first, we evaluate how many annotations are inconsistent
with these rules, and determine why they are inconsistent; second,
we use these rules to predict phenotypes from GO functions.
3.2 Determining consistency between function
annotations and phenotype annotations
We consider a regulation function annotation and regulatory pheno-
type annotation as consistent if they do not contradict our rules. An
inconsistent pair of annotations is a pair of function and phenotype
annotations which contradict our rules (i.e. the function annotation
is to the up- or down-regulation of a process and the phenotype of
the loss of function is an increased or decreased rate of that process).
We generated 423 GO–phenotype pairs that could represent an in-
consistency; of these 423 pairs, 398 pairs are GO–MP classes and 25
pairs are GO–HPO classes.
We determine whether the function and phenotype annotations
in the Mouse Genome Informatics (MGI) (Smith and Eppig, 2015)
model organism database are consistent with our hypothesis, and
whether the function annotations for human proteins provided by
UniProt (The UniProt Consortium, 2017) and the phenotypes asso-
ciated with these proteins provided by the HPO database (Robinson
et al., 2008; Ko¨hler et al., 2017) are consistent. In the first instance,
and to identify only unambiguously matching pairs, we ignore infer-
ences over the ontology and consider only exactly matching pheno-
types, i.e. only the annotations in which the direct annotation to the
phenotype matches our rule. We find 105 function–phenotype anno-
tation pairs for mouse and one annotation for human which are in-
consistent according to our set of inconsistent pairs.
We manually analyzed some of the annotations we tagged as in-
consistent with our rules. In many cases, inconsistency with our
rules may arise from conflicting GO or phenotype annotations. For
example, folliculin interacting protein 1 (Fnip1, MGI: 2444668) is
annotated with the GO function Positive regulation of B cell
apoptotic process (GO: 0002904), and the loss of function of
Fnip1 is annotated with the phenotype increased B cell apoptosis
(MP: 0008782). Using our rule (Increased Function–Decreased
Phenotype), we flagged this pair of annotations as inconsistent. Both
annotations are asserted based on evidence from the same publica-
tion (Park et al., 2012), which reports a negative regulatory role for
Fnip1 in B cell apoptosis and uses as experimental evidence that B
cell apoptosis is increased in response to metabolic stress in mice
lacking Fnip1 function. The reports in the paper, together with our
rule-based identification of the possible inconsistency, indicates that
the GO annotation of Fnip1 to Positive regulation of B cell apoptot-
ic process may not be correct and should be replaced by an annota-
tion to Negative regulation of B cell apoptotic process.
Another example involved glypican 3 (Gpc3, MGI: 104903),
which is annotated with the function Negative regulation of growth
and the phenotype Postnatal growth retardation. Here, the asserted
annotation to postnatal growth retardation is based on Chiao et al.
(2002). The postnatal growth catch-down and catch-up seen in
i860 M.Kulmanov et al.
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homozygote nulls was subject to extensive analysis in the paper and
the authors conclude that the normal, growth suppressing, function
of Gpc3 is restricted to the embryonic period. The knockout pheno-
type should therefore have been annotated as Increased embryo size,
not Postnatal growth retardation as the closest description to the
phenotype described in the paper.
The complexity of phenotypic annotations is well demonstrated
by the inconsistency we detect for an annotation of the CD28 cell sur-
face receptor. Annotated in GO to Positive regulation of T cell prolif-
eration, the knockout strain phenotype is annotated in MGI to
Increased T cell proliferation (Bour-Jordan et al., 2004). Regulatory T
cells (Tregs; CD4þCD25þ) depend on CD28 for activation and pro-
liferation. Effector T cells are suppressed in non-obese diabetic
(NOD) mice by active Tregs. In the absence of CD28, Tregs do not
proliferate, thereby permitting effector cells to proliferate. This prolif-
eration of effector T cells is reported in the manuscript on which the
phenotype annotation is based, and leads to the phenotype annotation
of the knockout. Formally this is accurate, but the phenotype reported
is dependent on the function of a cell type whose own function is
affected by the loss of CD28 in a different cell. This ‘russian doll’ ef-
fect is likely to be a significant confounder in relating phenotype to
function, particularly at a high level of phenotypic granularity.
We also experimented with extending the scope of our method
and included inferred phenotype annotations (we consider a pheno-
type annotation to phenotype class C as inferred if and only if the
annotation is made to a subclass of C in the phenotype ontology).
This allows us to identify significantly more potentially inconsistent
function–phenotype pairs. We find, for example, the inconsistent
annotation pair in BCL2-associated athanogene 6 (BAG6) between
the GO process Negative regulation of apoptotic process (GO:
0043066) and Decreased apoptosis (MP: 0006043). However, the
directly asserted annotation of BAG6 is to Decreased susceptibility
to neuronal excitotoxicity (MP: 0008236), a subclass of Decreased
apoptosis in MP. While a direct annotation to Decreased apoptosis
would likely have implied that apoptotic processes are, in general,
decreased in rate, an annotation to Decreased susceptibility to neur-
onal excitotoxicity does not have the same implications: apoptotic
processes occurring in neurons under certain conditions are
decreased in rate, but most apoptotic processes are unaffected. Due
to these implications, we do not apply our rules to phenotypes that
are inferred over a phenotype ontology.
3.3 Predicting phenotypes from functions
We can also use our rules to predict phenotypes from function anno-
tations. In this case, we take function annotations of a gene product
as input, and predict a phenotype that satisfies the definition in our
rules. Not all function annotations readily imply a phenotype; there-
fore, we cannot generate phenotype annotations for all proteins. We
generated 78 298 phenotype annotations for 10 041 human genes,
and 61 875 phenotype annotations for 7314 mouse genes. Of the
generated annotations, 116 human gene annotations and 3170
mouse gene annotations are already present in our data while the
remaining predictions are novel. Notably, we predict phenotype
annotations for 1986 genes that have no phenotype annotations at
all in the mouse, and for 7301 genes without any phenotype annota-
tions in the human. Table 1 summarizes our findings.
We evaluate the performance of our predictions using Fmax meas-
ure, which is a main evaluation metric of CAFA (Radivojac et al.,
2013) challenge. The Fmax measure provides a similarity for sets
of annotations which is computed over the ontology structure.
For predictions with experimental GO annotations we use a prediction
score of 1.0. Table 2 provides a summary of the evaluation results.
Phenotype annotations have many applications; in particular, it is
accepted that phenotypes reflect underlying physiological interactions
and networks (Costanzo et al., 2016) and phenotype annotations are
widely used to investigate the molecular basis of diseases (Ko¨hler
et al., 2009; Singleton et al., 2014). To validate our phenotype predic-
tions, we performed a set of experiments that provide an indirect, ex-
ternal validation of our predictions. Specifically, we apply a measure
of semantic similarity to compute the pairwise similarity between phe-
notypes associated with genes, and we use the gene–gene phenotypic
similarity to predict interactions between the genes [combining the
different interaction types aggregated in the STRING database
(Szklarczyk et al., 2015), including genetic interactions and protein–
protein interactions]. We evaluate our performance using a receiver
operating characteristic (ROC) curve (Fawcett, 2006). A ROC curve
is a plot of a classifiers true positive rate as a function of the false posi-
tive rate, and the area under the ROC curve (ROCAUC) is a quantita-
tive measure of a classifier’s performance (Fawcett, 2006). In our
evaluation, we rank pairs of genes based on their phenotype similarity
and treat interacting pairs (according to STRING) as positive instan-
ces and all other pairs as negative instances.
We observe that the performance for predicting interactions
improved even over the performance achieved with the original anno-
tations when using the phenotypes generated by our method.
Performance further improved when merging original and predicted
phenotype annotations, demonstrating that there is significant compli-
mentary information in both (see Table 3 and Figs 1 and 2). We also
observe a significant difference in predictive performance between
human and mouse; this is likely due to different protocols and stand-
ards used in generated both phenotype annotations and function
annotations, as well as the very low number of regulatory phenotype
annotation that are available for human genes and coded through the
HPO. In particular, since human phenotypes in the HPO database
predominantly focus on morphological abnormalities (in contrast to
mouse phenotypes encoded using the MP which balance morpho-
logical and physiological abnormalities), our predictive approach can
generate significant volumes of additional annotations that drastically
improve predictive performance in our indirect evaluation setting.
3.4 Predicting functions, predicting phenotype
annotations
Our method mainly relies on functional annotations of gene prod-
ucts. However, not all genes and gene products have experimental
Table 1. Number of predicted annotations using rules inferred with
ontology structure, and the number of annotations that are already
asserted
Predictions Increased Decreased Abnormal
Mouse
Predicted 61875 11656 4591 45628
Found 42175 370 503 41302
Human
Predicted 78298 18114 9588 50596
Found 13142 6 89 13047
Note: For inferred matches we assume that genotypes are annotated to all
superclasses of their annotated classes and propagate both functional and
phenotypic annotations. For example, if a genotype has the phenotype
Increased B cell apoptosis and application of our rule predicts increased apop-
tosis, we will also consider this as a match.
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functional annotations. Furthermore, the manual annotations
are often derived from mutant phenotypes, thereby limiting the
scope of our approach. However, with the recent advances in meth-
ods for computational prediction of protein functions (Cozzetto
et al., 2016; Gong et al., 2016; Kulmanov et al., 2017; Radivojac
et al., 2013), we can experiment with a two-step process: first,
we predict GO functions for proteins, and, second, we predict
phenotype annotations arising from a loss of function in the protein
using our rules.
We recently developed DeepGO (Kulmanov et al., 2017), a com-
putational method for function prediction which uses a deep neural
network algorithm to predict functions from protein sequence and
(when available) a cross-species interaction network. Using
DeepGO, we can predict functions for gene products with known
amino-acid sequences. From the predicted function, we can predict
phenotype annotations using our rules.
The DeepGO model can only predict annotations to 932 distinct
biological process classes in GO (Kulmanov et al., 2017). Of the
932 classes that DeepGO can predict, 443 classes are covered by our
rules, and 28 classes are negative regulations and 55 classes are posi-
tive regulations. We used DeepGO to predict at least one function
for 14 916 mouse and 17 837 human proteins, and based on them,
we generated phenotype annotations for 13 225 mouse and 14 187
human genes. 6033 mouse genes and 11 570 human genes for which
we predicted phenotypes do not currently have any experimental
phenotype annotations.
We evaluated our predictions using Fmax measure and by predict-
ing interactions from the STRING database, similarly to our evalu-
ation of phenotypes predicted from experimental GO annotations.
For computing Fmax measure, we used the prediction score of
DeepGO annotations as a prediction score for corresponding pheno-
type in our rules. We find that phenotype predictions with DeepGO
annotations for regulatory phenotypes performs better than predic-
tions with experimental GO annotations. Table 2 provides evalu-
ation results with Fmax measure.
Furthermore, we used predicted phenotype annotations for
predicting protein-protein interactions. Figures 1 and 2 show the
performance of predicting interactions in mouse and human, re-
spectively. We find that predicting phenotype annotations based on
DeepGO’s predicted functions allows us to further improve our abil-
ity to predict interactions in humans. For the mouse, however, the
performance of predicting interactions using phenotype annotations
generated from DeepGO’s predicted functions is slightly lower than
predictions based on experimental GO annotations, likely due to
phenotype annotations already being more complete in the mouse.
Table 3 provides a summary of the results.
Table 2. Evaluation of phenotype annotation predictions
Rules Number of genes Fmax
Mouse—Experimental GO Annotations
Increase/Decrease 2137 0.371
Abnormal 6753 0.367
All 6974 0.361
Mouse—DeepGO Annotations
Increase/Decrease 2030 0.424
Abnormal 6956 0.313
All 7675 0.189
Human—Experimental GO Annotations
Increase/Decrease 242 0.356
Abnormal 2453 0.252
All 2492 0.248
Human—DeepGO Annotations
Increase/Decrease 1290 0.647
Abnormal 2891 0.442
All 2891 0.439
Fig. 1. Predicting interactions using predicted phenotypes for mouse. Original
uses asserted phenotype annotations, Predicted uses only predicted pheno-
type annotations, and Merged combine asserted and predicted phenotype
annotations. DeepGO (Predicted) uses only predicted phenotype annotations
based on DeepGO’s predicted GO function annotations, and DeepGO
(Merged) combines them with asserted phenotype annotations
Fig. 2. Predicting interactions using predicted phenotype annotations for
human. Original uses asserted phenotype annotations, Predicted uses only
predicted phenotype annotations, and Merged combine asserted and pre-
dicted phenotype annotations. DeepGO (Predicted) uses only predicted
phenotype annotations based on DeepGO’s predicted GO function annota-
tions, and DeepGO (Merged) combines them with asserted phenotype
annotations
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4 Discussion
4.1 Rules and statistical approaches for predicting
phenotypes
Accurate prediction of the phenotypes of an organism from its geno-
type, and possibly some environmental features, is probably un-
achievable in the foreseeable future. However, some phenotypes
associated with some genes are sufficiently fundamental that they
can be predicted reliably given some basic knowledge about a gene
and the gene products it encodes. We identify three rules that estab-
lish a correspondence between functions of gene products and the
phenotypes that a loss of function in these gene products would en-
tail. The main limitation in applying our rules predictively is the pre-
cision with which function annotations are contextualized, i.e. how
universally a function annotation without any context constraints
should be interpreted. However, we focus on three rules which we
believe to be sufficiently robust to hold universally, almost as a con-
sequence of the definition of the corresponding phenotypes.
There are likely more rules that can be used to reliably predict
phenotypes from functions; some may be as simple as the rules we
propose, while others may require complex combinations of func-
tions, and additional constraints, to be applied. Rule mining techni-
ques (Bodenreider et al., 2005), in particular those that can utilize
axioms and rules in OWL (Lehmann, 2009), could identify more
rules of varying strength and may provide an opportunity to further
extend our approach.
We demonstrated that we could not only apply our rules to ex-
perimentally determined function predictions, but we were also able
to use a function prediction method to predict GO functions, then
apply our rules and predict phenotypes. While this approach already
yields phenotypes that are useful in computational methods (such as
similarity-based prediction of protein–protein interactions), some
technical modifications could further improve the accuracy and
coverage of predicting phenotypes. A main limitation is that both
parts of the method are trained and generated separately; an end-to-
end learning approach in which phenotypes are predicted directly
(and in which the DeepGO model—or another function prediction
method—is used as intermediate, pre-trained part) may further im-
prove the performance as well as coverage of our method.
4.2 Morphological and physiological abnormalities
We found that the performance of our methods is significantly lower
in human proteins compared to mouse proteins. However, the num-
ber of physiological phenotypes in the HPO, i.e. phenotypes that are
defined as an abnormality of a process or function, is much smaller
in the HPO than it is in the MP; while HPO mainly contains mor-
phological and developmental abnormalities, MP has a rich classifi-
cation of abnormal processes.
Our method uses the PhenomeNET ontology (Rodrı´guez-Garcı´a
et al., 2017) for prediction; PhenomeNET integrates the MP and
HPO and therefore predicts many physiological abnormalities for
human proteins which cannot currently be captured using the HPO,
but which could be captured using the MP. We observe that the
under-representation of physiological abnormalities in the HPO
results in a low predictive performance (e.g. Fmax measure) when
comparing against annotations of human proteins, because our
method over-predicts many phenotype annotations. However, our
external validation using prediction of interactions between proteins
demonstrates that our predictions are highly useful and complemen-
tary to the existing phenotype annotations of human proteins; add-
ing our predictions leads to a high increase in ROCAUC when
predicting interactions between proteins. In the future, more human
physiological abnormalities could be added to and defined in the
HPO so that such information can be captured about human genes.
4.3 What do phenotype annotations mean?
Our method can be used both to identify possibly conflicting anno-
tations as well as to suggest phenotypes that may arise from a par-
ticular genotype. One observation from our experiments is that the
meaning of the annotation relation can be different depending on
whether the annotation is asserted or inferred using the ontology
structure. Specifically, there seems to be a difference between anno-
tations to a phenotype such as Increased apoptosis, depending on
whether the annotation is inferred from the ontology hierarchy (as
in the case of an annotation to Increased B cell apoptosis), or
asserted. If the annotation is asserted at the level of the class
Increased apoptosis, we would usually expect all types of apoptosis
processes in the organism to be increased in rate, including apoptosis
of B cells and other specific cell types. However, if the annotation is
to a more specific class, such as increased B cell apoptosis from
which an annotation to Increased apoptosis can be inferred, this no
longer holds true.
We can use OWL to provide the outlines of a data model in
which these considerations are made explicit. Let us assume that X
is annotated with the phenotype P, and, without loss of generality,
that P is defined as an increased rate of process F. There are multiple
different options for formalizing the meaning of this annotation.
The ‘weakest’ form of interpretation (i.e. the form from which the
least amount of information can be derived) would be that an organ-
ism with X (e.g. an organism with a loss of function mutation in X)
would have a part in which at least one process of type F can be
observed to be increased in rate; formally, the organism with X
would be a subclass of has-part some [(inverse occurs-in) some
(F and has-quality some ‘increased rate’)]. A stronger interpretation
could be that all processes of type F occurring in an organism with
X would be increased in rate. In this case, processes of type F that
occur in an organism with X would be come a subclass of things
with increased rate, i.e, (F and occurs-in some X) SubClassOf: has-
quality some ’increased rate’.
From the first interpretation and its formal representation, we
cannot conclude that processes of type F will always, or usually, be
Table 3. Summary of evaluation of prediction phenotype annota-
tions for mouse and human
Method AUC
(original)
AUC
(predicted)
AUC
(merged)
Mouse
Interactions with
experimental
GO annotations
0.667 0.672 0.705
Interactions with
DeepGO
annotations
0.667 0.696 0.694
Human
Interactions with
experimental GO
annotations
0.616 0.749 0.902
Interactions with
DeepGO
annotations
0.616 0.741 0.928
Note: Original uses asserted phenotype annotations, Predicted uses
only predicted phenotype annotations, and Merged combine asserted and
predicted phenotype annotations.
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increased in rate. We can also not infer much information about
subclasses of the phenotype P; we can only infer that the organism
with X would also be annotated to any superclass of P. In the second
case, however, we can infer that X would also be annotated with all
subclasses of P (but not with its superclasses).
To avoid ambiguity in interpretation of phenotype annotations,
it would be beneficial to make their intended meaning clear, in par-
ticular as the inferences that can be drawn from the interpretations
are different. There have already been some efforts to integrate
annotations and ontologies in a single knowledge-based model
(Hoehndorf et al., 2016; Santana da Silva et al., 2017) which can be
used as a formalized data model. Future work on formalizing the
intended meaning of annotations, and the adoption of a semantic
model, would further improve interoperability and reuse of these
annotations and thereby improving their compliance with FAIR
standards (Wilkinson et al. 2016).
5 Conclusions
We have developed a novel rule-based method for predicting pheno-
types from functions. Our approach can be used as a method to val-
idate phenotype annotations in literature-curated databases, and
also to predict phenotypes from a loss of function genotype in a re-
verse genetics manner (Gilchrist and Haughn, 2010). While the pre-
diction of phenotypes from genotypes is going to remain a
challenge, our approach has implications for computational meth-
ods that utilize phenotypes. We demonstrated that the phenotypes
we predict are predictive of interactions; using a multi-step method
in which we first predict protein functions from sequence and then
phenotypes from the functions, we could predict phenotypes for
genes which have not yet been investigated using a reverse genetic
screen. Our approach can therefore extend the scope of phenotype-
based methods, including methods for predicting variants, disease
genes, or candidate drugs, to cover a significantly larger portion of
the mammalian phenome.
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